Which has the lower trailing P/E, GDRX or IRMD?

IRMD has the lower trailing P/E: GDRX trades at 76.94 and IRMD at 47.39. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GDRX or IRMD?

Over the past five years, IRMD grew revenue faster — GDRX at a 4.47% CAGR versus IRMD at 19.60%.

Does GDRX or IRMD pay a bigger dividend?

IRMD pays a dividend (1.47% yield), while GDRX has no payments in the available dividend history.

Is GDRX or IRMD more profitable?

IRMD runs the higher net margin — GDRX at 2.07% versus IRMD at 26.70%.

How have GDRX and IRMD total returns compared?

Over the past 5 years, GDRX delivered -39.98% and IRMD delivered 24.06% annualized total return. Past performance doesn't predict future results.

GoodRx Holdings, Inc. (GDRX) vs IRadimed Corporation (IRMD)

A side-by-side comparison of GoodRx Holdings, Inc. and IRadimed Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GDRX

GoodRx Holdings, Inc.

$1.13B

$3.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

IRMD

IRadimed Corporation

$1.08B

$84.82HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GDRX vs IRMD

growth of $100 · dividends reinvested · last 6y

GDRX -93.3% (-36.3%/yr)IRMD +326.3% (+27.3%/yr)IRMD compounded faster over this window

Log scale — wide-divergence pair

GDRX IRMD

GDRX vs IRMD: by the numbers

•GDRX is the larger company ($1.13B vs $1.08B market cap).
•IRMD trades at the lower trailing earnings multiple (47.39 vs 76.94 P/E), one valuation lens rather than an overall verdict.
•IRMD converts more revenue to profit (26.70% vs 2.07% net margin).
•IRMD grew revenue faster over the past five years (19.60% vs 4.47% CAGR).
•IRMD pays a dividend (1.47% yield), while GDRX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	GDRX	IRMD
P/E ratio	76.94	47.39
Forward P/E	N/A	40.14
PEG ratio	N/A	0.64
P/S ratio	1.44	12.56
P/B ratio	1.75	10.66
EV / EBITDA	8.14	34.85
FCF yield	12.86%	2.30%

Profitability

Metric	GDRX	IRMD
Gross margin	88.05%	75.86%
Operating margin	10.25%	31.92%
Net margin	2.07%	26.70%
ROE	2.51%	22.66%
ROIC	3.72%	20.18%

Dividends

Metric	GDRX	IRMD
Dividend yield	N/A	1.47%
Payout ratio	N/A	70.95%

Growth (annualized)

Metric	GDRX	IRMD
Revenue CAGR (5Y)	4.47%	19.60%
EPS CAGR (5Y)	N/A	74.32%
FCF CAGR (5Y)	11.72%	26.20%
Total return CAGR (5Y)	-39.98%	24.06%

Frequently asked

Which has the lower trailing P/E, GDRX or IRMD?: IRMD has the lower trailing P/E: GDRX trades at 76.94 and IRMD at 47.39. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GDRX or IRMD?: Over the past five years, IRMD grew revenue faster — GDRX at a 4.47% CAGR versus IRMD at 19.60%.
Does GDRX or IRMD pay a bigger dividend?: IRMD pays a dividend (1.47% yield), while GDRX has no payments in the available dividend history.
Is GDRX or IRMD more profitable?: IRMD runs the higher net margin — GDRX at 2.07% versus IRMD at 26.70%.
How have GDRX and IRMD total returns compared?: Over the past 5 years, GDRX delivered -39.98% and IRMD delivered 24.06% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GDRX analysis Full IRMD analysis Interactive comparison tool

Dig into the metrics

GoodRx P/E ratio IRadimed P/E ratio IRadimed dividend yield GoodRx ROE IRadimed ROE GoodRx operating margin IRadimed operating margin GoodRx revenue growth IRadimed revenue growth GoodRx free cash flow IRadimed free cash flow

GoodRx & IRadimed appear in these rankings

Fastest Revenue Growth Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.